2022
DOI: 10.1038/s41467-022-34407-1
|View full text |Cite
|
Sign up to set email alerts
|

Connecting multiple microenvironment proteomes uncovers the biology in head and neck cancer

Abstract: The poor prognosis of head and neck cancer (HNC) is associated with metastasis within the lymph nodes (LNs). Herein, the proteome of 140 multisite samples from a 59-HNC patient cohort, including primary and matched LN-negative or -positive tissues, saliva, and blood cells, reveals insights into the biology and potential metastasis biomarkers that may assist in clinical decision-making. Protein profiles are strictly associated with immune modulation across datasets, and this provides the basis for investigating… Show more

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
8
0

Year Published

2022
2022
2025
2025

Publication Types

Select...
5
1

Relationship

1
5

Authors

Journals

citations
Cited by 10 publications
(8 citation statements)
references
References 88 publications
0
8
0
Order By: Relevance
“…This protein was also previously identified with higher abundance in nonmalignant cells from lymph nodes compared to primary tumor’s cells . Although TKT has a recognized prognostic role in tumoral tissue, , its contribution to saliva has yet to be determined.…”
Section: Resultsmentioning
confidence: 90%
See 3 more Smart Citations
“…This protein was also previously identified with higher abundance in nonmalignant cells from lymph nodes compared to primary tumor’s cells . Although TKT has a recognized prognostic role in tumoral tissue, , its contribution to saliva has yet to be determined.…”
Section: Resultsmentioning
confidence: 90%
“…Prioritization was based on the following criteria: (1) top hit in ranking attribute method analysis; (2) clinical correlation with prognostic features; (3) identifications in previous studies as differentially abundant proteins from nonmalignant cells of primary OSCC tumors compared to committed lymph nodes …”
Section: Methodsmentioning
confidence: 99%
See 2 more Smart Citations
“…The detection of marker levels in patients prior to treatment is widely used to assess the occurrence of clinical events, disease recurrence or progression, and survival outcomes, thereby helping clinicians and researchers guide the monitoring of cancer patients and make decisions about personalized treatment [1][2][3]. Tumor prognostic markers are currently being studied in numerous areas, including genomics [4,5], transcriptomics [6][7][8], proteomics [9,10], metabolomics [11], and epigenomics [12,13]. Among these, the investigation of transcriptomic prognostic markers has been a hot area of research in the last decade owing to the rapid development of microarray and high-throughput sequencing technologies, which researchers have used to uncover a large number of potential molecular mechanisms of gene expression differences leading to disease development and clinical applications.…”
Section: Introductionmentioning
confidence: 99%